Final Report ACHEMA 2024

Record internationality, record attendee numbers at the congress, satisfied exhibitors

24-Jun-2024 - At ACHEMA 2024, the world's leading trade show for the process industries, 2,842 exhibitors from 56 nations showed 106,001 participants from 141 countries the latest equipment and innovative processes for the chemical, pharmaceutical, food processing and related industries at the Frankfurt ...

Celonic Inaugurates “Next Generation” Biologics Development Center (BDC) and Pilot Plant in Basel, Switzerland

Reducing the cost and risks of scaling-up biologic medicine production

20-Jun-2024 - TheCelonic Group, a Swiss Based Quality Biologics Contract Development and Manufacturing Organization (CDMO) today opened its “Next Generation” Biologics Development Center and Pilot Plant in Basel, Switzerland. This laboratory expansion will help pharmaceutical companies develop and optimize ...

A fungus converts cellulose directly into a novel platform chemical

A new process for the mass production of erythro-isocitric acid from waste could make the substance interesting for industry in the future

27-May-2024 - The fungus Talaromyces verruculosus can produce the chemical erythro-isocitric acid, which has received little attention on the market to date, directly from cheap plant waste and thus make it interesting for industrial utilization. Using the natural abilities of the non-genetically modified ...

Sartorius collaborates with Sanofi to

Commercialization of end-to-end platform for downstream process intensification

20-May-2024 - The life science group Sartorius is collaborating with biopharmaceutical company Sanofi to develop an end-to-end platform for integrated and continuous downstream bioprocessing. Selected as a preferred supplier, Sartorius will contribute its engineering and manufacturing expertise to ...

TU Graz Bundles Its Strengths in Biotechnology and Artificial Intelligence

09-May-2024 - In a multidisciplinary research project, researchers from the biosciences, process engineering and computer science want to massively increase efficiency in the development of new enzymes and process optimization. This should even enable the breakdown of forever chemicals. Graz University of ...

POWTECH to rebrand as POWTECH TECHNOPHARM from 2025

07-Jul-2023 - POWTECH, the International Processing Trade Fair for Powder, Bulk Solids, Fluids and Liquids, is expanding its importance as the technology platform for the processing sector, and will in future operate under a new branding as POWTECH TECHNOPHARM. POWTECH 2023 will take place under its known ...

Merck Announces Collaboration with Agilent Technologies

Collaboration will help enable real-time release and Bioprocessing 4.0

15-Jun-2022 - Merck announced that it has entered a collaboration with Agilent Technologies to advance Process Analytical Technologies (PAT). PAT, which is strongly encouraged by global regulatory authorities, is a key enabler for real-time release and Bioprocessing 4.0. “The biopharmaceutical industry is on a ...

The 7th BioProScale Symposium took place again as in-person event in Berlin

New ways of thinking are required: Scientists from both academia and industry presented and discussed innovative approaches and developments in biotechnology and bioprocess engineering

12-Apr-2022 - On the subject of “Scaling Up and Down of Bioprocesses: Technological Innovation and Cell Physiology Insights”,the 7thSymposium was again held on-site in Berlin from March 28 to31,2022. In parallel, there was also the possibility to follow the presentations online. The symposium was organized ...

Merck Advances BioProcessing Capabilities

Acquisition of MAST® Platform from Lonza, a Automated Bioreactor Sampling System

07-Apr-2022 - Merck will advance its bioprocessing portfolio with the acquisition of the MAST® (Modular Automated Sampling Technology) platform from Lonza. The MAST® platform is an automated, aseptic bioreactor sampling system developed in Bend, Oregon, USA. The financial details of the deal were not ...

Gene therapy start-up VectorY and Wageningen University sign strategic collaboration

Two-part project to develop novel baculovirus genome seeds and bioprocess technologies for the scalable production of AAV gene therapies

27-Jan-2022 - VectorY Therapeutics, a biotech company focusing on the development of innovative gene therapy approaches for the treatment of muscular and neurodegenerative disorders through vectorized antibodies, announces a collaboration with Wageningen University to develop novel baculovirus-based ...